Potential herd protection against plasmodium falciparum infections conferred by mass antimalarial drug administrations

eLife

Volumn 8, Issue , 2019, Pages

  Parker, Daniel M ^a   Tun, Sai Thein Than ^b,c   White, Lisa J ^b,c   Kajeechiwa, Ladda ^d   Thwin, May Myo ^d   Landier, Jordi ^e   Chaumeau, Victor ^c,d,e,f   Corbel, Vincent ^e   Dondorp, Arjen M ^b,c   Von Seidlein, Lorenz ^c   White, Nicholas J ^b,c   Maude, Richard J ^b,c,g   Nosten, François ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^e UNIV MONTPELLIER   (France)

^f MONTPELLIER UNIVERSITY HOSPITAL   (France)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASYMPTOMATIC INFECTION; CHILD; CONTROLLED STUDY; FEMALE; HERD IMMUNITY; HUMAN; INFANT; MALARIA FALCIPARUM; MALE; MASS DRUG ADMINISTRATION; MIDDLE AGED; MOSQUITO BITE; NEWBORN; NONHUMAN; PATHOGEN LOAD; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SCHOOL CHILD; SPATIOTEMPORAL ANALYSIS; TREATMENT REFUSAL; ASYMPTOMATIC DISEASE; CLUSTER ANALYSIS; ISOLATION AND PURIFICATION; MEDICATION COMPLIANCE; MYANMAR; RURAL POPULATION;

ANTIMALARIALS; ASYMPTOMATIC DISEASES; CLUSTER ANALYSIS; HUMANS; MALARIA, FALCIPARUM; MASS DRUG ADMINISTRATION; MEDICATION ADHERENCE; MYANMAR; PLASMODIUM FALCIPARUM; RURAL POPULATION; SPATIO-TEMPORAL ANALYSIS;

EID: 85064931674     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.41023     Document Type: Article

References (31)

1. Bancone G, Chu CS, Somsakchaicharoen R, Chowwiwat N, Parker DM, Charunwatthana P, White NJ, Nosten FH. Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border. PLoS ONE. 2014;9:e116063. DOI: Https://doi.org/10.1371/journal.pone.0116063.
2. Chu CS, Bancone G, Moore KA, Win HH, Thitipanawan N, Po C, Chowwiwat N, Raksapraidee R, Wilairisak P, Phyo AP, Keereecharoen L, Proux S, Charunwatthana P, Nosten F, White NJ. Haemolysis in G6PD heterozygous females treated with primaquine for plasmodium vivax malaria: A nested cohort in a trial of radical curative regimens. PLOS Medicine. 2017;14:e1002224. DOI: Https://doi.org/10.1371/journal.pmed.1002224.
3. Cotter C, Sturrock HJ, Hsiang MS, Liu J, Phillips AA, Hwang J, Gueye CS, Fullman N, Gosling RD, Feachem RG. The changing epidemiology of malaria elimination: New strategies for new challenges. The Lancet. 2013;382:900-911. DOI: Https://doi.org/10.1016/S0140-6736(13)60310-4.
4. Gitaka J, Chan C, Kongere J, Kagaya W, Kaneko A. Mass drug administration (MDA) INTEGRATED malaria elimination in a hypo-endemic island in lake victoria, kenya. BMJ Global Health. 2017;2:A14.1-A14. DOI: Https://doi.org/10.1136/bmjgh-2016-000260.33.
5. Imwong M, Hanchana S, Malleret B, Rénia L, Day NP, Dondorp A, Nosten F, Snounou G, White NJ. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. Journal of Clinical Microbiology. 2014;52:3303-3309. DOI: Https://doi.org/10.1128/JCM.01057-14.
6. Imwong M, Nguyen TN, Tripura R, Peto TJ, Lee SJ, Lwin KM, Suangkanarat P, Jeeyapant A, Vihokhern B, Wongsaen K, Van Hue D, Dong le T, Nguyen TU, Lubell Y, von Seidlein L, Dhorda M, Promnarate C, Snounou G, Malleret B, Rénia L, Keereecharoen L, Singhasivanon P, Sirithiranont P, Chalk J, Nguon C, Hien TT, Day N, White NJ, Dondorp A, Nosten F. The epidemiology of subclinical malaria infections in South-East Asia: Findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam. Malaria Journal. 2015;14:1-13. DOI: Https://doi.org/10.1186/s12936-015-0906-x.
7. John TJ, Samuel R. Herd immunity and herd effect: New insights and definitions. European Journal of Epidemiology. 2000;16:601-606. DOI: Https://doi.org/10.1023/A:1007626510002.
8. Keenan JD, Hotez PJ, Amza A, Stoller NE, Gaynor BD, Porco TC, Lietman TM. Elimination and eradication of neglected tropical diseases with mass drug administrations: A survey of experts. PLoS Neglected Tropical Diseases. 2013;7:e2562-e2568. DOI: Https://doi.org/10.1371/journal.pntd.0002562.
9. Koenker HM, Loll D, Rweyemamu D, Ali AS. A good night’s sleep and the habit of net use: Perceptions of risk and reasons for bed net use in Bukoba and Zanzibar. Malaria Journal. 2013;12:1-12. DOI: Https://doi.org/10.1186/1475-2875-12-203.
10. Kulldorff M. A spatial scan statistic. Communications in Statistics-Theory and Methods. 1997;26:1481-1496. DOI: Https://doi.org/10.1080/03610929708831995.
11. Landier J, Kajeechiwa L, Thwin MM, Parker DM, Chaumeau V, Wiladphaingern J, Imwong M, Miotto O, Patumrat K, Duanguppama J, Cerqueira D, Malleret B, Rénia L, Nosten S, von Seidlein L, Ling C, Proux S, Corbel V, Simpson JA, Dondorp AM, White NJ, Nosten FH. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of eastern Myanmar. Wellcome Open Research. 2017a;2:81. DOI: Https://doi.org/10.12688/wellcomeopenres.12240.1.
12. Landier J, Kajeechiwa L, Thwin MM, Parker DM, Chaumeau V, Wiladphaingern J, Imwong M, Miotto O, Patumrat K, Duanguppama J, Cerqueira D, Malleret B, Rénia L, Nosten S, von Seidlein L, Ling C, Proux S, Corbel V, Simpson JA, Dondorp AM, White NJ, Nosten FH. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of eastern Myanmar. Wellcome Open Research. 2017b;2:81. DOI: Https://doi.org/10.12688/wellcomeopenres.12240.1.
13. Landier J, Parker DM, Thu AM, Lwin KM, Delmas G, Nosten FH, Andolina C, Aguas R, Ang SM, Aung EP, Baw NB, Be SA, B'Let S, Bluh H, Bonnington CA, Chaumeau V, Chirakiratinant M, Cho WC, Christensen P, Corbel V, Day NPJ, Dah SH, Delmas G, Dhorda M, Dondorp AM, Gaudart J, Gornsawun G, Haohankhunnatham W, Hla SK, Hsel SN, Htoo GN, Htoo SN, Imwong M, John S, Kajeechiwa L, Kereecharoen L, Kittiphanakun P, Kittitawee K, Konghahong K, Khin SD, Kyaw SW, Landier J, Ling C, Lwin KM, Lwin KSW, Ma Naw K Yin, Marie A, Maung C, Marta E, Minh MC, Miotto O, Moo PK, Moo KL, Moo M, Na NN, Nay M, Nosten FH, Nosten S, Nyo SN, Oh EKS, Oo PT, Oo TP, Parker DM, Paw ES, Phumiya C, Phyo AP, Pilaseng K, Proux S, Rakthinthong S, Ritwongsakul W, Salathibuphha K, Santirad A, Sawasdichai S, von Seidlein L, Shee PW, Shee PB, Tangseefa D, Thu AM, Thwin MM, Tun SW, Wanachaloemlep C, White LJ, White NJ, Wiladphaingern J, Win SN, Yee NL, Yuwapan D. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on plasmodium falciparum malaria in eastern Myanmar: An observational study of a regional elimination programme. The Lancet. 2018a;391:1916-1926. DOI: Https://doi.org/10.1016/S0140-6736(18)30792-X.
14. Landier J, Parker DM, Thu AM, Lwin KM, Delmas G, Nosten FH, Andolina C, Aguas R, Ang SM, Aung EP, Baw NB, Be SA, B'Let S, Bluh H, Bonnington CA, Chaumeau V, Chirakiratinant M, Cho WC, Christensen P, Corbel V, Day NPJ, Dah SH, Delmas G, Dhorda M, Dondorp AM, Gaudart J, Gornsawun G, Haohankhunnatham W, Hla SK, Hsel SN, Htoo GN, Htoo SN, Imwong M, John S, Kajeechiwa L, Kereecharoen L, Kittiphanakun P, Kittitawee K, Konghahong K, Khin SD, Kyaw SW, Landier J, Ling C, Lwin KM, Lwin KSW, Ma Naw K' Yin, Marie A, Maung C, Marta E, Minh MC, Miotto O, Moo PK, Moo KL, Moo M, Na NN, Nay M, Nosten FH, Nosten S, Nyo SN, Oh EKS, Oo PT, Oo TP, Parker DM, Paw ES, Phumiya C, Phyo AP, Pilaseng K, Proux S, Rakthinthong S, Ritwongsakul W, Salathibuphha K, Santirad A, Sawasdichai S, von Seidlein L, Shee PW, Shee PB, Tangseefa D, Thu AM, Thwin MM, Tun SW, Wanachaloemlep C, White LJ, White NJ, Wiladphaingern J, Win SN, Yee NL, Yuwapan D. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on plasmodium falciparum malaria in eastern Myanmar: An observational study of a regional elimination programme. The Lancet. 2018b;391:1916-1926. DOI: Https://doi.org/10.1016/S0140-6736(18)30792-X.
15. Manning J, Lon C, Spring M, Wojnarski M, Somethy S, Chann S, Gosi P, Soveasna K, Sriwichai S, Kuntawunginn W, Fukuda MM, Smith PL, Rekol H, Sinoun M, So M, Lin J, Satharath P, Saunders D. Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: A study protocol to define malaria elimination strategies in Cambodia. Trials. 2018;19:1-13. DOI: Https://doi.org/10.1186/s13063-018-2931-x.
16. Mwesigwa J, Achan J, Affara M, Wathuo M, Worwui A, Muhommed NI, Kanuteh F, Prom A, Dierickx S, di Tanna GL, Nwakanma D, Bousema T, Drakeley C, Van Geertruyden JP, D'Alessandro U. Mass drug administration with dihydroartemisinin-piperaquine and malaria transmission dynamics in The Gambia-a prospective cohort study. Clinical Infectious Diseases. 2018;2 DOI: Https://doi.org/10.1093/cid/ciy870.
17. Nguyen TN, von Seidlein L, Nguyen TV, Truong PN, Hung SD, Pham HT, Nguyen TU, Le TD, Dao VH, Mukaka M, Day NP, White NJ, Dondorp AM, Thwaites GE, Hien TT. The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: An open cohort study. The Lancet Infectious Diseases. 2018;18:565-572. DOI: Https://doi.org/10.1016/S1473-3099(18)30046-X.
18. Parker DM, Landier J, von Seidlein L, Dondorp A, White L, Hanboonkunupakarn B, Maude RJ, Nosten FH. Limitations of malaria reactive case detection in an area of low and unstable transmission on the Myanmar-Thailand border. Malaria Journal. 2016;15:71. DOI: Https://doi.org/10.1186/s12936-016-1631-9.
19. Parker DM, Landier J, Thu AM, Lwin KM, Delmas G, Nosten FH, Malaria Elimination Task Force Group Scale up of a Plasmodium falciparum elimination program and surveillance system in Kayin State, Myanmar. Wellcome Open Research. 2017;2:98. DOI: Https://doi.org/10.12688/wellcomeopenres.12741.1.
20. Pinotti M, LOBO AG, DAMASCENO G, Soares R. [Field tests of chloroquin-table salt mixture] Revista Brasileira De Malariologia E Doencas Tropicais. Publicacoes Avulsas. 1955;7:5-23.
21. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database of Systematic Reviews. 2013 DOI: Https://doi.org/10.1002/14651858.CD008846.pub2.
22. Pollard SL, Malpica-Llanos T, Friberg IK, Fischer-Walker C, Ashraf S, Walker N. Estimating the herd immunity effect of rotavirus vaccine. Vaccine. 2015;33:3795-3800. DOI: Https://doi.org/10.1016/j.vaccine.2015.06.064.
23. Pongvongsa T, Phommasone K, Adhikari B, Henriques G, Chotivanich K, Hanboonkunupakarn B, Mukaka M, Peerawaranun P, von Seidlein L, Day NPJ, White NJ, Dondorp AM, Imwong M, Newton PN, Singhasivanon P, Mayxay M, Pukrittayakamee S. The dynamic of asymptomatic plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos. Malaria Journal. 2018;17:1-13. DOI: Https://doi.org/10.1186/s12936-018-2541-9.
24. Shekalaghe SA, Drakeley C, van den Bosch S, ter Braak R, van den Bijllaardt W, Mwanziva C, Semvua S, Masokoto A, Mosha F, Teelen K, Hermsen R, Okell L, Gosling R, Sauerwein R, Bousema T. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malaria Journal. 2011;10:247. DOI: Https://doi.org/10.1186/1475-2875-10-247.
25. Tripura R, Peto TJ, Chea N, Chan D, Mukaka M, Sirithiranont P, Dhorda M, Promnarate C, Imwong M, von Seidlein L, Duanguppama J, Patumrat K, Huy R, Grobusch MP, Day NPJ, White NJ, Dondorp AM. A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages. Clinical Infectious Diseases. 2018;67:817-826. DOI: Https://doi.org/10.1093/cid/ciy196.
26. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 2002;418:320-323. DOI: Https://doi.org/10.1038/nature00813.
27. World Health Organization. Guidelines for the Treatment of Malaria. 3rd editio. Geneva: World Health Organization; 2015a.
28. World Health Organization. Mass Drug Administration, Mass Screening and Treatment and Focal Screening and Treatment for Malaria. World Health Organization; 2015b.
29. World Health Organization. Mass Drug Administration for Falciparum Malaria: A Practical Field Manual. Geneva: World Health Organization; 2017.
30. Ya-Umphan P, Cerqueira D, Parker DM, Cottrell G, Poinsignon A, Remoue F, Brengues C, Chareonviriyaphap T, Nosten F, Corbel V. Use of an anopheles salivary biomarker to assess malaria transmission risk along the Thailand-Myanmar border. The Journal of Infectious Diseases. 2017;215 DOI: Https://doi.org/10.1093/infdis/jiw543.
31. Zuber JA, Takala-Harrison S. Multidrug-resistant malaria and the impact of mass drug administration. Infection and drug resistance. 2018;11:299-306. DOI: Https://doi.org/10.2147/IDR.S123887.